Figure 7
AECMV cargo transfer promoted an immunosuppressive response in PBMCs and Jurkat cells
(A) PHA-stimulated PBMCs ± Anti-CD44 and ± EIPA were treated with the different CM (AEC ± LPSMV and AEC± LPSMV-free) for 48h and assessed for their proliferation. Data were normalized on PHA-stimulated PBMCs (100% of proliferation).
(B) CD3/CD28-stimulated Jurkat reporter cells ± Anti-CD44 and ± EIPA were evaluated for the inhibition of NFAT activation after treatment with the different CM (±LPS) for 48h. Data were normalized on CD3/CD28 stimulated Jurkat (100% of NFAT activation). Data (mean ± SD) represent 3 independent sets of experiments (n = at least 3 biological replicates in each group per set; each biological replicate assayed in at least 3 technical replicates). ALL, ∗, ∗∗, ∗∗∗, and ∗∗∗∗ Statistically significant values between the different studied groups (